Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.

Pharmaceutical

Evotec

Craig Johnstone

Laetitia Rouxel

Cord Dohrmann

Hans-Ulrich Wolf

The Information Technology Team at Evotec plays a crucial role in supporting the company’s drug discovery and development efforts by developing and maintaining the technological infrastructure that enables research and innovation. This team focuses on creating and implementing software solutions, ensuring system reliability, managing IT projects, and providing technical support to enhance operational efficiency across various drug discovery segments. By leveraging cutting-edge technology and strategic IT initiatives, the team facilitates collaboration and data management critical to advancing Evotec’s drug discovery programs.

Information Technology Team

Scientific Research Team

Leadership Team

Business Development and Strategy Team

Information Technology Team

About

Team members

Other teams at Evotec

Scientific Research Team

Leadership Team

Business Development and Strategy Team